Specialty Pharmacy 3.1

SDrM 4 – Prospective, Concurrent, and Retrospective Drug Management

Submited by: Tom Goddard

The Basics

If your pharmacy is contracted to conduct prospective, concurrent, and retrospective reviews, it must implement policies that such reviews involve a consideration of, where appropriate, the following issues:

  • Therapeutic appropriateness; 
  • Over and underutilization;
  • Generic use;
  • Therapeutic interchange;
  • Duplication;
  • Drug-disease contraindications;
  • Drug-drug or drug-allergy interactions; 
  • Drug dosage;
  • Duration of treatment;
  • Clinical abuse or misuse;
  • Drug-age precautions;
  • Drug-gender precautions;
  • Drug-pregnancy precautions; and
  • Regulatory limitations.
Most of these issues are addressed by modern pharmacy dispensing software programs. 

Management Tips

If your organization is required by contract, or is likely to be required by contract, to do any of these types of reviews, your P&P needs to address all 14 types of review, even those types not in your current contractual requirements. Make sure your policies describe both the technological and human resource aspects of these requirements, i.e., who is doing what and with what tools, computer and otherwise, should be explicitly stated.

Accreditation Tips

Desktop Review
At this stage of the process, submit both your P&P and examples of the capabilities of your drug utilization management system. Screen shots are an excellent way to let the reviewer see how things work with your software, particularly if you provide an explanation in the "Notes" section of the citation accompanying the screen shots.
If your pharmacy is not in the business of conducting drug utilization management, submit an attestation to that effect.
Validation Review
Interviews
The reviewer will interview your clinical staff involved with drug utilization management to assess compliance with your P&Ps. 
Document Review
The reviewer will review how your drug utilization management process works by examining randomly selective files from a log of requests for prospective, concurrent, and retrospective review requests.

  • Specialty Pharmacy 3.1 / 03.25.2019

    SDrM 6 - Patient Safety Process Requirements

    This standard requires that your pharmacy maintain a robust program for addressing patient safety issues. That program needs to have the capability of:Identification and reporting of adverse drug events;Reporting such events to external entities (e.g., payers, MedWatch, PSO);Identification and management of risk;Disclosing clinically significant errors to affected patients and their caregivers;Ide...

    READ FULL POST
  • Specialty Pharmacy 3.1 / 03.25.2019

    SDrM 5 – Drug Utilization Management Reporting

    This brief standard simply requires that your pharmacy has a mechanism by which it provides a report on the drug utilization management program to the quality management committee ("QMC") or some other committee that oversees quality management.The content of that report is up to the pharmacy, but URAC has an expectation that it will include such information as:The volume of utilization reviews, s...

    READ FULL POST
  • Specialty Pharmacy 3.1 / 03.25.2019

    SDrM 4 – Prospective, Concurrent, and Retrospective Drug Management

    If your pharmacy is contracted to conduct prospective, concurrent, and retrospective reviews, it must implement policies that such reviews involve a consideration of, where appropriate, the following issues:Therapeutic appropriateness; Over and underutilization;Generic use;Therapeutic interchange;Duplication;Drug-disease contraindications;Drug-drug or drug-allergy interactions; Drug dosage;Duratio...

    READ FULL POST
Top